Sign in
Taking peopleNo phase

Orbital atherectomy for hardened leg arteries in chronic limb-threatening ischemia

Follows 250 people with chronic limb-threatening ischemia treated with orbital atherectomy.

Key facts

Who runs it
Cardiovascular and Interventional Radiological Society of Europe
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
Status
Recruiting
People taking part
250 people, planned
Started
31 Aug 2026
Expected to end
Dec 2031
Type of study
Observational
Treatments tested
  • Stealth 360™ Peripheral Orbital Atherectomy System from Abbott
Record updated
23 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic limb-threatening ischemia, a severe lack of blood flow to the leg. They must have hard, calcium-filled arteries in the thigh or lower leg that will be treated with the Stealth 360 orbital atherectomy device.

Age
18 Years and older
Sex
All
Disease stage
Rutherford category 4 or higher. Calcified narrowings in the femoropopliteal or infrapopliteal arteries, visible on fluoroscopy or CT-angiography.
Earlier treatment
No endovascular procedure (treatment from inside the blood vessel) on the treatment site within 4 weeks before the study procedure.

Main reasons for not taking part

  • Pregnant or breastfeeding women, minors, and people who cannot give consent freely
  • Poor blood flow into the treated area (more than 30% narrowing) after it has been improved
  • Fewer than 1 open artery carrying blood below the treated area
  • A planned amputation above the ankle on the treated leg
  • Taking part in the RESCUE trial (NCT07270575)

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Rutherford classification category ≥4
  • Treatment of femoropopliteal or infrapopliteal calcified lesions with OA using the Stealth 360 peripheral OA System
  • Calcification of target lesions must be visible on fluoroscopy or CT-angiography
  • Patients competent and willing to provide informed consent

Who cannot take part

  • Endovascular procedure(s) on the treatment site within 4 weeks before index procedure
  • Minors and other vulnerable populations who may not be able to give informed consent freely or for whom participation is not essential to the study (incapacitated and unconscious individuals, persons deprived of liberty, pregnant and breastfeeding women, etc.)
  • Inadequate inflow (>30% stenosis) following optimization
  • Insufficient direct outflow (less than 1 run-off vessel)
  • Patients planned to receive an above ankle amputation of the target limb
  • Patients enrolled in RESCUE (ClinicalTrials.gov ID NCT07270575)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.

The group in the trial

  • Adult CLTI patients with femoropopliteal or infrapopliteal calcified lesions

    Eligible patients are those who will undergo OA prior to any adjunctive endovascular procedure

    Treatment: Stealth 360™ Peripheral Orbital Atherectomy System from Abbott

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
Plain-language title
Orbital atherectomy for hardened leg arteries in chronic limb-threatening ischemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
23 September 2026